These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 11816473

  • 1. [Tumor markers in malignant lymphoma].
    Banno S, Ueda R.
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):149-53. PubMed ID: 11816473
    [Abstract] [Full Text] [Related]

  • 2. [Tumor markers in malignant lymphoma].
    Kato H, Ogura M.
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [Abstract] [Full Text] [Related]

  • 3. Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
    Oertel J, Kingreen D, Busemann C, Stein H, Dörken B.
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):182-8. PubMed ID: 11935308
    [Abstract] [Full Text] [Related]

  • 4. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Obermann EC, Went P, Pehrs AC, Tzankov A, Wild PJ, Pileri S, Hofstaedter F, Dirnhofer S.
    Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A, Mann G, Dworzak M, Trebo M, Urban C, Fink FM, Horcher E, Reiter A, Riehm H, Gadner H, Austrian Cooperative Study Group.
    Wien Klin Wochenschr; 2002 Dec 30; 114(23-24):978-86. PubMed ID: 12635465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS, Huang WT, Hsieh PP, Tseng HH, Campo E, Colomer D, Ye H, Lu CL, Chang HM, Cho CY, Huang SH, Lu YC, Wu JD.
    Pathol Int; 2006 Aug 30; 56(8):440-8. PubMed ID: 16872438
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study].
    Ohno H, Ishikawa T, Kitajima H, Nomura S, Suzuki T, Konishi H, Ohno Y, Onishi R, Konaka Y, Arima N, Doi S, Nasu K, Takahashi T, Tsudo M, Fukuhara S, Uchiyama T.
    Rinsho Ketsueki; 2002 Mar 30; 43(3):170-5. PubMed ID: 11979748
    [Abstract] [Full Text] [Related]

  • 17. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
    Chang PM, Chen PM, Hsieh SL, Tzeng CH, Liu JH, Chiou TJ, Wang WS, Yen CC, Gau JP, Yang MH.
    Int J Oncol; 2008 Sep 30; 33(3):549-54. PubMed ID: 18695885
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical significance of biological prognostic factors in non-Hodgkin lymphoma: analysis of serum and cell surface nm 23-H1 protein].
    Niitsu N.
    Rinsho Ketsueki; 2003 Apr 30; 44(4):211-8. PubMed ID: 12784653
    [No Abstract] [Full Text] [Related]

  • 20. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
    Tzankov A, Gschwendtner A, Augustin F, Fiegl M, Obermann EC, Dirnhofer S, Went P.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2125-32. PubMed ID: 16609025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.